| IKT Average Annual Return Chart Since 2020 | |||
Also see: • IKT stock yearly return 2021 • IKT stock yearly return 2022 • IKT stock yearly return 2023 • IKT stock yearly return 2024 • IKT YTD return | |||
| Average Annual Return Benchmarks |
|
Compare IKT average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| IKT Share Performance |
| IKT Average Annual Return Table Since 2020 | ||||||||||||||||||||||||||||||
IKT average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Inhibikase Therapeutics Inc |
| Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company. Co. is focused on developing therapeutics for Parkinson's disease and related disorders. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its lead program risvodetinib (also known as IkT-148009), an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The IKT average annual return since 2020 is shown above.
The Average Annual Return on the IKT average annual return since 2020 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether IKT average annual return since 2020 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the IKT average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| IKT Current Stock Quote |
 Free IKT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Inhibikase Therapeutics (IKT) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
ILMN Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!